ENGMAB AG has a total of 51 patent applications. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ARGEN X BV, XENCOR INC and ULTRAHUMAN EIGHT LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 9 | |
#3 | United States | 8 | |
#4 | Canada | 5 | |
#5 | China | 5 | |
#6 | Australia | 3 | |
#7 | Hong Kong | 3 | |
#8 | Singapore | 3 | |
#9 | Hungary | 1 | |
#10 | Morocco | 1 | |
#11 | Montenegro | 1 | |
#12 | Serbia | 1 | |
#13 | Slovenia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Microorganisms | |
#6 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Strein Klaus | 48 |
#2 | Vu Minh Diem | 42 |
#3 | Freimoser-Grundschober Anne | 39 |
#4 | Ast Oliver | 39 |
#5 | Klein Christian | 39 |
#6 | Moessner Ekkehard | 39 |
#7 | Moser Samuel | 39 |
#8 | Umana Pablo | 39 |
#9 | Fauti Tanja | 37 |
#10 | Hosse Ralf | 36 |
Publication | Filing date | Title |
---|---|---|
WO2017021450A1 | Monoclonal antibodies against bcma | |
WO2016055593A1 | Bispecific antibodies against cd3epsilon and ror1 for use in the treatment of ovarian cancer | |
AU2015329965A1 | Bispecific antibodies against CD3epsilon and ROR1 | |
EP3029068A1 | Bispecific antibodies against CD3epsilon and BCMA for use in the treatment of diseases | |
EP3023437A1 | Bispecific antibodies against CD3epsilon and BCMA | |
EP2982692A1 | Bispecific antibodies against CD3epsilon and BCMA | |
CN104968682A | Bispecific antibodies against CD3[epsilon] and BCMA | |
EP2789630A1 | Bispecific antibodies against CD3e and ROR1 | |
EP2762496A1 | Method for the selection of antibodies against BCMA | |
EP2762497A1 | Bispecific antibodies against CD3epsilon and BCMA |